Topics
Glioblastoma | Treatment | Clinical trials | Microenvironment modulators
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Microenvironment modulators
Chen
JJ, Vincent MY, Shepard D, Peereboom D, Mahalingam D, Battiste J,
Patel MR, Juric D, Wen PY, Bullock A, Selfridge JE, Pant S, Liu J,
Li W, Fyfe S, Wang S, Zota V, Mahoney J, Watnick RS, Cieslewicz M,
Watnick J.
Phase
1 dose expansion and biomarker study assessing first-in-class
tumor microenvironment modulator VT1021 in patients with advanced
solid tumors.
Commun
Med (Lond).
2024 May 21;4(1):95. doi:
10.1038/s43856-024-00520-z. PMID:
38773224. Interventional study. ˍ